* Mibyeong Research Center, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 305-811, Republic of Korea.
‡ Department of Korean Medical Scinece, School of Korean Medicine, Pusan National University, Gyeongnam, Yansan 626-870, Republic of Korea.
Am J Chin Med. 2017;45(4):757-772. doi: 10.1142/S0192415X17500409. Epub 2017 May 18.
Atherosclerosis was previously thought to be a disease that primarily involves lipid accumulation in the arterial wall. In this report, we investigated the effect of Viola mandshurica W. Becker (V. mandshurica) water extract on atherosclerosis in apolipoprotein E deficient (ApoE[Formula: see text]) mice. The administration of V. mandshurica to high-fat diet-fed mice reduced body weight, liver weight, and serum levels of lipids (total cholesterol, low-density lipoprotein-cholesterol, triglycerides), glucose, alanine transaminase, and aspartate transaminase. Histopathologic analyses of the aorta and liver revealed that V. mandshurica attenuated atherosclerotic lesions and reduced lipid accumulation, inflammatory responses and fatty acid synthesis. V. mandshurica also increased phosphorylation of adenosine monophosphate-activated protein kinase (AMPK), thereby reducing acetyl-CoA carboxylase (ACC) in liver tissue and inhibiting sterol regulatory element-binding protein 1c (SREBP-1c). V. mandshurica reduced protein expression levels of adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin) as well as ACC, fatty acid synthase, and SREBP-1c. In addition, quantitative analysis of V. mandshurica by high-performance liquid chromatography revealed the presence of esculetin and scopoletin. Esculetin and scopoletin reduced adhesion molecules in human aortic smooth muscle cells. Our results indicate that the anti-atherosclerotic effects of V. mandshurica may be associated with activation of the AMPK pathway. Therefore, AMPK-dependent phosphorylation of SREBP-1c by V. mandshurica may be an effective therapeutic strategy for combatting atherosclerosis and hepatic steatosis.
动脉粥样硬化以前被认为是一种主要涉及动脉壁中脂质积累的疾病。在本报告中,我们研究了堇菜属(Viola mandshurica W. Becker)水提取物对载脂蛋白 E 缺陷(ApoE[Formula: see text])小鼠动脉粥样硬化的影响。堇菜属水提物给药可降低高脂饮食喂养小鼠的体重、肝重和血清脂质(总胆固醇、低密度脂蛋白胆固醇、甘油三酯)、葡萄糖、丙氨酸转氨酶和天冬氨酸转氨酶水平。主动脉和肝脏的组织病理学分析表明,堇菜属可减轻动脉粥样硬化病变,减少脂质积累、炎症反应和脂肪酸合成。堇菜属还增加了腺苷一磷酸激活蛋白激酶(AMPK)的磷酸化,从而减少了肝组织中的乙酰辅酶 A 羧化酶(ACC),并抑制了固醇调节元件结合蛋白 1c(SREBP-1c)。堇菜属还降低了黏附分子(细胞间黏附分子-1、血管细胞黏附分子-1 和 E-选择素)以及 ACC、脂肪酸合酶和 SREBP-1c 的蛋白表达水平。此外,高效液相色谱法对堇菜属的定量分析显示存在秦皮素和瑞香素。秦皮素和瑞香素降低了人主动脉平滑肌细胞中的黏附分子。我们的结果表明,堇菜属的抗动脉粥样硬化作用可能与 AMPK 通路的激活有关。因此,堇菜属通过 AMPK 依赖性磷酸化 SREBP-1c 可能是对抗动脉粥样硬化和肝脂肪变性的有效治疗策略。